Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Removes waste products (e.g., urea, creatinine) and excess fluid from the blood through peritoneal dialysis by diffusion and osmosis across the peritoneal membrane.
Inpersol-ZM w/ Dextrose 1.5% is a peritoneal dialysis solution that acts by creating a concentration gradient across the peritoneal membrane. The dextrose component provides an osmotic driving force that promotes ultrafiltration and removal of waste products (e.g., urea, creatinine) and excess electrolytes from the blood into the dialysate fluid, which is then drained from the peritoneal cavity. The electrolyte composition (sodium, chloride, calcium, magnesium, lactate) helps correct acid-base and electrolyte imbalances.
Intraperitoneal administration: 2 liters per exchange, 4 exchanges daily; dwell time 4-6 hours; concentration selected based on ultrafiltration needs.
250 mL to 2 L intraperitoneally, instilled over 10-20 minutes, dwell for 4-6 hours, then drain. Typically 4 exchanges per day.
None Documented
None Documented
The terminal half-life of icodextrin (as total icodextrin-derived oligosaccharides) is approximately 5-8 hours after a single dwell, reflecting clearance from the plasma compartment. Clinically, sustained levels can occur with repeated exchanges.
Not applicable systemically; dextrose half-life is minutes due to rapid cellular uptake. In peritoneal dialysis, the half-life of glucose in the peritoneal cavity is approximately 30-60 minutes due to absorption into bloodstream.
Delflex-LM with Dextrose 1.5% (icodextrin) is a peritoneal dialysis solution. Icodextrin is metabolized to oligosaccharides and primarily eliminated via the peritoneal cavity during dialysis. Renal excretion is minimal (<1%). The majority of icodextrin and its metabolites are removed with the dialysate effluent.
Renal: 100% (dialysis fluid containing dextrose is removed directly; glucose is metabolized and not excreted unchanged). Dextrose undergoes cellular metabolism to CO2 and water.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution